An Open Label Exploratory Study Evaluating the Efficacy and Safety of Ingenol Mebutate 0.05% Gel for the Treatment of Verruca Vulgaris.
Phase of Trial: Phase I
Latest Information Update: 19 Jul 2017
At a glance
- Drugs Ingenol mebutate (Primary)
- Indications Warts
- Focus Therapeutic Use
- 12 Jul 2017 Status changed from recruiting to completed.
- 26 Apr 2016 New trial record